News
-
-
-
-
-
PRESS RELEASE
Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)
Telomir Pharmaceuticals, Inc. announces groundbreaking results in preclinical studies for AMD treatment, showcasing Telomir-1's ability to reverse oxidative damage in retinal cells -
-
-
PRESS RELEASE
Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses
Telomir Pharmaceuticals, Inc. announces groundbreaking results in reversing oxidative stress challenges and cellular protection. Telomir-1 shows promise in addressing age-related diseases and viral infections -
-